Skip to main content
SpringerLink
Log in

Psychotropic Medications in Individuals with Intellectual Disability

  • Chapter
  • First Online:
Guide to Intellectual Disabilities

  • 1177 Accesses

Abstract

The decision to prescribe psychotropic medications to patients with intellectual disability (ID) should be carefully considered because persons with ID are more vulnerable to side effects of medications, including extrapyramidal and metabolic side effects. The strategies and recommendations that follow should be tailored to each individual after a comprehensive and thorough examination of the patient and a discussion about the risks, benefits, potential side effects, and alternative treatment options with the patient and caregiver/guardian.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fletcher RJ, Barnhill J, Cooper SA. DM-ID-2: diagnostic manual-intellectual disability: a textbook of diagnosis of mental disorders in persons with intellectual disability. Washington D.C.: National Assn for the Dually Diagnosed Press; 2016.

    Google Scholar 

  2. Gentile JP, Gillig PM, editors. Psychiatry of intellectual disability: a practical manual. Hoboken: John Wiley & Sons; 2012.

    Google Scholar 

  3. Stahl SM, Stahl SM. Stahl’s essential psychopharmacology: neuroscientific basis and practical applications. Cambridge: Cambridge university press; 2013.

    Google Scholar 

  4. Stern TA, et al. Massachusetts General Hospital psychopharmacology and neurotherapeutics e-book. London: Elsevier Health Sciences; 2015.

    Google Scholar 

  5. Stahl SM. The prescriber’s guide. Cambridge: Cambridge University Press; 2011.

    Google Scholar 

  6. Jenkins JA, Kontos N. The Maudsley prescribing guidelines in psychiatry. J Clin Psychiatry. 2016;77(4):469.

    Article  Google Scholar 

  7. Puzantian T, Balt S. The Carlat psychiatry report medication fact book for psychiatric practice: 2nd edition. Newburyport: Carlat Publishing; 2014.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. San Antonio Military Medical Center, Houston, TX, USA

    David W. Dixon

Authors
  1. David W. Dixon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David W. Dixon .

Editor information

Editors and Affiliations

  1. Department of Psychiatry, Wright State University, Dayton, OH, USA

    Julie P. Gentile

  2. Department of Psychiatry, Wright State University, Dayton, OH, USA

    Allison E. Cowan

  3. San Antonio Military Medical Center, Houston, TX, USA

    David W. Dixon

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dixon, D.W. (2019). Psychotropic Medications in Individuals with Intellectual Disability. In: Gentile, J., Cowan, A., Dixon, D. (eds) Guide to Intellectual Disabilities. Springer, Cham. https://doi.org/10.1007/978-3-030-04456-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-04456-5_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-04455-8

  • Online ISBN: 978-3-030-04456-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation